학술논문

Targeting anti-PD1-resistant tumors via indoleamine 2,3-dioxygenase 1 (IDO1) inhibition.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2017, 35 5p. Supplement: 15
Subject
Language
English
ISSN
15277755